Ligand to Participate in September Investor Conferences
Provided By GlobeNewswire
Last update: Aug 19, 2025
JUPITER, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will participate in the following upcoming investor conferences:
Read more at globenewswire.com
